What is OutSee?
OutSee is a pioneering force in the field of predictive genomics, utilizing its proprietary Nomaly engine to redefine drug target discovery. By applying sophisticated AI algorithms to genomic datasets, the company uncovers biological drivers of disease that remain obscured by traditional analytical methods. This capability allows OutSee to extract actionable insights from smaller or previously analyzed datasets, effectively unpicking complex genetic architectures. The company's market position is bolstered by strategic alliances with high-profile organizations such as Genomics England and FinnGen, validating its utility in both therapeutic development and patient stratification for precision medicine applications.
How much funding has OutSee raised?
OutSee has raised a total of $5.9M across 1 funding round:
Seed
$5.9M
Seed (2026): $5.9M with participation from Empirical Ventures, Ahren Innovation Capital, Panacea Ventures, and Kadmos Capital
Key Investors in OutSee
Empirical Ventures
Empirical Ventures is a specialist venture capital firm focused on investing in Europe's early-stage, deep-tech ventures, combining scientific expertise with financial backing for Life Sciences and TechBio innovations.
Ahren Innovation Capital
Ahren Innovation Capital is an investment institution focused on supporting transformational companies at the intersection of deep technology and deep science, with a specific interest in Genetics and Platform Technologies.
Panacea Ventures
Panacea Ventures is a global healthcare venture fund dedicated to transforming lives through investments in life sciences, focusing on next-generation immunotherapeutic modalities and regenerative medicine.
What's next for OutSee?
With this major strategic investment, OutSee is poised to accelerate its commercialization strategy and broaden the application of the Nomaly platform. The company's roadmap includes scaling its internal drug discovery capabilities and enhancing its patient stratification tools to meet the growing demand for personalized healthcare solutions. By maintaining its focus on deep-tech integration and high-value partnerships, OutSee is well-positioned to navigate the complexities of the biotech landscape, aiming to translate its predictive insights into tangible clinical outcomes that address significant unmet medical needs.
See full OutSee company page
